Brandinium

Trademark search for:

LUMINERA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2020-09-13 — Application filed
  • 2020-10-08 — Sn assigned for sect 66a subseq desig from ib
  • 2020-10-14 — Application filed
  • 2020-10-20 — Application filed
  • 2021-01-25 — Assigned to examiner
  • 2021-02-01 — Final disposition recorded
  • 2021-02-02 — Office action issued
  • 2021-02-11 — Office action issued
  • 2021-02-11 — Office action issued
  • 2021-02-28 — Office action issued
  • 2021-08-10 — Correspondence received in law office
  • 2021-08-10 — Office action issued
  • 2021-08-11 — Teas/email correspondence entered
  • 2021-08-13 — Change of owner received from ib
  • 2021-10-06 — Final disposition recorded
  • 2021-10-06 — Final disposition recorded
  • 2021-10-06 — Final disposition recorded
  • 2021-11-08 — Office action issued
  • 2022-03-09 — Notification of possible opposition created, to be sent to ib
  • 2022-03-09 — Notification of possible opposition sent to ib
  • 2022-03-26 — Notification of possible opposition - processed by ib
  • 2022-03-28 — Correspondence received in law office
  • 2022-03-28 — Office action issued
  • 2022-03-30 — Teas/email correspondence entered
  • 2022-04-26 — Approved for pub - principal register
  • 2022-05-11 — Notification of notice of publication e-mailed
  • 2022-05-31 — Published for opposition
  • 2022-05-31 — Official gazette publication confirmation e-mailed
  • 2022-08-16 — Registered-principal register
  • 2022-08-16 — Notice of registration confirmation emailed
  • 2022-11-16 — Final disposition recorded
  • 2022-11-22 — Generic madrid transaction created
  • 2022-11-22 — Generic madrid transaction sent to ib
  • 2023-01-03 — Final disposition recorded
  • 2024-09-17 — Final status recorded
  • 2025-04-12 — Death of international registration
  • 2025-04-12 — Notification of effect of cancellation of intl reg e-mailed

Owner Information

Allergan Pharmaceuticals International Limited
IE
Allergan Pharmaceuticals International Limited
IE
Allergan Pharmaceuticals International Limited
IE
Panaxia Ltd
IL

Correspondent

Matthew O. Brady AbbVie Inc.
2525 Dupont Drive
Irvine, CA 92612
UNITED STATES

Filing Details

Filing Date:
2020-09-13
Status Date:
2024-09-17
Category:
Pharmaceuticals
Filing Year:
2020

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.